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Review
Oral Rabies Vaccination in North America: Opportunities,
Complexities, and Challenges
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Blanton4, Michael Niezgoda4, Charles E. Rupprecht4
1USDA/APHIS/Wildlife Services, National Rabies Management Program, Concord, New Hampshire, United States of America, 2USDA/APHIS/Wildlife Services, National
Rabies Management Program, Castleton, New York, United States of America, 3Ontario Ministry of Natural Resources, Wildlife Research and Development Section, Rabies
Research and Development Unit, Peterborough, Ontario, Canada, 4Centers for Disease Control and Prevention, Division of Viral and Rickettsial Diseases, Rabies Section,
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Abstract: Steps to facilitate inter-jurisdictional collabora-
tion nationally and continentally have been critical for
implementing and conducting coordinated wildlife rabies
management programs that rely heavily on oral rabies
vaccination (ORV). Formation of a national rabies man-
agement team has been pivotal for coordinated ORV
programs in the United States of America. The signing of
the North American Rabies Management Plan extended a
collaborative framework for coordination of surveillance,
control, and research in border areas among Canada,
Mexico, and the US. Advances in enhanced surveillance
have facilitated sampling of greater scope and intensity
near ORV zones for improved rabies management
decision-making in real time. The value of enhanced
surveillance as a complement to public health surveillance
was best illustrated in Ohio during 2007, where 19 rabies
cases were detected that were critical for the formulation
of focused contingency actions for controlling rabies in
this strategically key area. Diverse complexities and
challenges are commonplace when applying ORV to
control rabies in wild meso-carnivores. Nevertheless,
intervention has resulted in notable successes, including
the elimination of an arctic fox (Vulpes lagopus) rabies
virus variant in most of southern Ontario, Canada, with
ancillary benefits of elimination extending into Quebec
and the northeastern US. Progress continues with ORV
toward preventing the spread and working toward
elimination of a unique variant of gray fox (Urocyon
cinereoargenteus) rabies in west central Texas. Elimination
of rabies in coyotes (Canis latrans) through ORV contrib-
uted to the US being declared free of canine rabies in
2007. Raccoon (Procyon lotor) rabies control continues to
present the greatest challenges among meso-carnivore
rabies reservoirs, yet to date intervention has prevented
this variant from gaining a broad geographic foothold
beyond ORV zones designed to prevent its spread from
the eastern US. Progress continues toward the develop-
ment and testing of new bait-vaccine combinations that
increase the chance for improved delivery and perfor-
mance in the diverse meso-carnivore rabies reservoir
complex in the US.
Introduction
Oral rabies vaccination (ORV) represents a socially acceptable
methodology that may be applied on a broad geographic scale to
manage the disease in specific terrestrial wildlife reservoirs, as well
as in free-ranging or feral dog (Canis familiaris) populations, where
parenteral vaccination is impractical. The integration of ORV into
conventional prevention and control strategies signifies a paradigm
shift toward the achievement of effective rabies control in
terrestrial wild Carnivora and feral dog reservoirs. Inherent to
interventions targeting specific reservoirs are the benefits associ-
ated with reduced risk of human and animal exposure to rabies.
Moreover, success in geographically confining or reducing
terrestrial rabies virus diversity should facilitate an enhanced
focus on the public and animal health dilemma associated with
rabies in bats in the US and elsewhere in North America.
To date, ORV has been successfully applied to eliminate rabies
among red foxes (Vulpes vulpes) in several European countries [1,2],
with continued expansion of control programs into eastern Europe
[3]. Ontario, Canada has nearly achieved elimination of the arctic
fox (V. lagopus) variant of rabies virus, once widespread in red foxes
throughout the southern part of the province [4,5]. However, the
virus currently persists in isolated foci in southwestern Ontario as a
result of spill-over into skunks (Mephitis mephitis) [6] and the lack of
an effective oral vaccine-bait formulation for use in skunks [7].
Development and field testing of a human adenovirus-rabies
glycoprotein recombinant (ONRAB [Artemis Technologies Inc.,
Guelph, Ontario, Canada]) with proven effectiveness in skunks
holds promise for total elimination of the arctic fox rabies variant
in southern Ontario [8,9]. ORV has also been used to successfully
control a canine rabies virus variant that had spilled over into
coyotes (C. latrans) in south Texas [10,11]. Its integration into the
control strategy as an adjunct to parenteral vaccination in dogs has
been credited as a major contributing factor leading to canine
rabies free status for the US (declared in 2007 based on World
Health Organization [WHO] standards [12,13]).
Currently, ORV use in the US remains focused on preventing
raccoon (Procyon lotor) rabies from expanding its geographic
foothold beyond the eastern US and Canada, and as a component
of potential strategies for raccoon rabies elimination [14,15].
Additional programs are focused on containing and eliminating a
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variant of gray fox (Urocyon cinereoargenteus) rabies in west Texas,
and preventing the reemergence of canine rabies from Mexico
[11,13].
Each ORV program is faced with multiple complexities [15],
but none is as formidable as those associated with control of rabies
in the raccoon. As an ecological generalist, raccoons often occur
at extremely high population densities along the rural-urban
interface [16] in common with the distribution of this rabies virus
variant. Indeed, a major underlying impetus for the integration of
ORV into conventional prevention and control beginning in the
1990s was the potential for accrued public health benefits of
preventing continued spread of raccoon rabies within the eastern
US [17] where much of the country’s human population resides
[18]. In turn, the increased chance for human-raccoon interac-
tions and the difficulties of conducting control programs in the
suburban mosaic along this interface poses unique and diverse
challenges to rabies control.
This paper draws largely from specific examples of contempo-
rary wildlife rabies control programs in North America to illustrate
key ecological, biological, logistical, and environmental complex-
ities and challenges, and the initiatives taken to achieve success.
Methods
Literature searches included the use of Scopus via access
through the USDA National Agricultural Library, and EBSCO
Host Academic Search Premier via the University of New
Hampshire’s Dimond Library. Assistance in publication acquisi-
tion was provided by the USDA, Wildlife Services National
Wildlife Research Center Library staff. Keyword searches
included the following terms: rabies, wildlife and rabies, ORV, TVR,
rabies host shift, and others.
North American Collaboration Approaches
A broad scientific, regulatory, and management interface exists
among the public health, agriculture, and wildlife management
agencies responsible for specific rabies prevention and control
activities in the US. Each state and federal agency has statutory
authority and a public trust niche to achieve specific agency missions.
As a consequence, planning, implementing, and coordinating
effective rabies prevention and control necessitates inter-jurisdic-
tional collaboration among diverse disciplines and authorities.
A national rabies management team approach has been applied
in the US since 1999 to facilitate coordination of ORV programs
across state and international boundaries in North America
targeting specific rabies virus host reservoirs. The National Rabies
Management Team is currently composed of nine smaller working
groups focused on key topic areas such as surveillance, vaccine
development, rabies control strategies, and research prioritization.
The team meets annually to assess and discuss key issues and
provides guidance for a spectrum of national wildlife rabies
prevention and control goals [15]. The approach taken to assure
science-based wildlife rabies control in the US is embodied in the
‘‘One Health Initiative’’ [19], a renewed global strategy
recognizing that human and animal health, including wildlife,
are inextricably linked. To effectively address infectious zoonotic
diseases like rabies requires expanded interagency communication
and collaboration. This national approach has been used as a
springboard to develop a continental framework for rabies
prevention and control in North America.
The signing of the North American Rabies Management Plan
(NARMP) in October 2008 by representatives from Canada,
Mexico, the US, and the Navajo Nation extends collaboration
across national boundaries and multiple disciplines in four focus
areas: communications, surveillance, control, and research. A
fundamental tenet of the NARMP is that rabies prevention and
control programs can be enhanced through an international
collaborative framework. The formalization of this plan has
spawned several proposed collaborative initiatives for 2009.
Examples include a comparison of ORV performance between
New Brunswick, Canada, and Maine, US, and closer coordination
between border states and provinces involved in raccoon rabies
control. Other examples include replication of the first ORV
campaigns targeting dogs in Mexico, improved enhanced rabies
surveillance along the Mexico-US border, and captive studies with
the GnRH immunocontraceptive GonaCon in Mexico [20].
Value of Enhanced Surveillance to ORV
Rabies surveillance is traditionally based on human or domestic
animal exposure events brought to the attention of public health
officials [12]. This system is effective in providing surveillance data
to support critical medical decisions to protect public health.
However, exposure-based surveillance tends to be biased by
human population densities, political enumeration units, and other
factors. This approach may not include a sufficient sampling scope
or intensity to accurately delineate the leading edge of specific
rabies virus variant distributions in real time or with the relatively
high degree of confidence required for the timely and effective
allocation of resources to ORV.
Enhanced rabies surveillance to support ORV in the US focuses
on the following types of samples: strange acting (extremely
aggressive or docile) animals where no human or domestic animal
exposure has been reported, road kills, animals found dead in
addition to road kills, animals with injuries or lesions indicative of
highly aggressive behavior, and euthanized animals from focal
trapping at sites where rabid animals were recently confirmed. Not
uncommonly, raccoons captured by nuisance wildlife control
operators are included as enhanced rabies samples [21],
particularly when they can help delineate rabies distribution
where control is being planned in suburban settings.
The enhanced surveillance zone for raccoons typically extends
from the areas where raccoon rabies is enzootic, through the ORV
zone, to approximately 80 km into areas suspected to be free of
raccoon rabies (Figure 1). The spatio-temporal distribution of
animals tested for rabies is subsequently mapped using RabID (a
geographic information system [GIS] database and internet
mapping application) [22] such that near real-time decisions can
be made to increase surveillance in areas, adjust ORV zones, or
implement other rabies management actions such as trap-
vaccinate-release (TVR).
Substantial increases in suspect rabid animal samples under the
enhanced rabies surveillance protocol often create an undue
burden on state laboratories for timely diagnosis. Application of a
direct rapid immunohistochemistry test (dRIT) developed at the
Centers for Disease Control and Prevention (CDC) in the US
[23,24] has permitted trained biologists in several states to mitigate
much of this burden, while achieving the goal of expanding the
geographic scope and intensity of rabies surveillance. In 2007,
Wildlife Services (WS) tested 7,737 animals using the dRIT to
enhance surveillance of raccoon rabies; 167 tested positive. In
some states (e.g., New York), enhanced surveillance samples
continue to be tested in a timely fashion by the state health rabies
laboratory using the direct fluorescent antibody (dFA) test and
virus typing by a US national protocol [25].
The value of enhancing rabies surveillance beyond levels
typically conducted for the protection of public health was
illustrated in northeast Ohio during 2007. This area is character-
ized by heavy commercial business and residential developments
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typical of suburbia (Cleveland metropolitan area). Since 2004,
when rabies was first detected in this area (10 km west of the
existing Appalachian ORV zone at that time), surveillance has
been enhanced resulting in WS submitting 5,554 animals (through
2008) for rabies testing. In each year except 2007, rabies positive
cases were detected through the public health surveillance system
as well. From 2004–2006, there had been declining rabies cases,
suggesting a trend toward rabies-free status in this contingency
action area. In 2007, all rabies positive cases in this area were
detected as a function of enhanced surveillance (Figure 2). This
was a somewhat surprising result given the opportunity for
exposure and presence of rabies in this highly developed suburban
setting, underscoring the value of enhanced surveillance as a
complement to traditional public health surveillance. The
distribution of these positive cases (Figure 3) was critical to
obtaining emergency funding and formulating a focused TVR
campaign to bolster population immunity in an attempt to restore
the area to raccoon rabies-free status.
Raccoon Rabies ORV
Raccoon rabies was first described in Florida in the 1940s [26],
and until the mid-1970s remained confined to the far southeastern
US, extending north into South Carolina and west into Alabama
[27]. Purposeful human-assisted translocations of raccoons to
portions of western Virginia and southern West Virginia
documented in the 1970s resulted in the creation of a new
‘‘Mid-Atlantic’’ raccoon rabies epizootic focus [28,29]. Lack of
access to ORV at the initiation of the outbreak or other practical
methods that may have been applied on a landscape scale
prevented intervention around the original focus. Unchecked, this
unique virus variant spread rapidly in the ubiquitous and
abundant raccoon populations of eastern North America. Thus,
it has come to occupy its current expanded range from
southwestern Alabama to the Maine–New Brunswick, Canada
border and west to northeast Ohio, with emergence into southern
Quebec (north of the Vermont border) in 2006 [12].
During the 1990s, coordinated operational raccoon rabies
control programs in the US expanded from small scale projects in
five states (Florida, Massachusetts, Maryland, New Jersey, New
York) to include portions of 16 states by 2005 [30]. A series of
ORV zones have been strategically created to prevent raccoon
rabies from spreading to unaffected areas. Mean post-ORV
antibody activity ($0.05 IU) for participating states as an index to
population immunity for raccoons has averaged around 30% in
these zones (Figure 4), with 2007, the most recent year with
complete information, at 33.2%615.5% (standard deviation).
These observed antibody levels are low in comparison to the long-
term annual average reported for gray foxes (61%) and coyotes
(63%) [11] in states using the same oral rabies vaccine and similar
baiting strategies. Nevertheless, raccoon rabies has not spread
appreciably beyond ORV zones where abundant susceptible
raccoon populations exist [31,32] based on the expected rate of
movement as observed in the eastern US [33], or as modeled for
Ohio by Russell et al. [34], in the absence of ORV intervention.
Obviously, lower indices to population immunity connote a
greater risk of ORV zone compromise and a reduced ability to
sustain effective programs, highlighting the need for improved or
new baits and vaccines and strategy refinements. Frequent
spillover of raccoon rabies virus variant into the striped skunk
[12] represents an additional confounding factor for long-term
success [35], as essentially no antibody response has been observed
in serum samples collected from skunks within ORV zones
targeting raccoons [21]. Both factors have contributed to the need
to apply contingency actions to bolster ORV campaigns to achieve
rabies management goals. For example, use of population
reduction, TVR (effective in skunks) and ORV in point infection
control (PIC) in Ontario [36,37], and a modified PIC in New
Brunswick (M Allan, personal communication) have been credited
with restoring both provinces to raccoon ‘‘rabies-free’’ status. In
2006 and 2007, PIC was conducted in southern Quebec to try to
prevent raccoon rabies that emerged north of the ORV zone in
Vermont from spreading north to Montreal and other human-
occupied areas (P Canac-Marquis, personal communication).
In the US, a contingency action has continued in northeast
Ohio since 2004, when raccoon rabies emerged 10 km west of the
established ORV zone [15]. The strategy included ORV baiting
by hand and by air twice/year (often at bait densities of up to
150 baits/km2), intensive enhanced surveillance, and TVR. In
2008, 4,196 raccoons were parenterally vaccinated in treatment
cells (Figure 3), based on a priori raccoon population density
indices, to achieve a targeted 65% vaccination rate. Additionally,
138 raccoons and 77 skunks were sampled and tested for rabies.
Post-treatment serum analysis is in progress. Those results, in
Figure 1. Raccoon oral rabies vaccination and Wildlife Services’
enhanced surveillance counties in the United States of
America, 2007.
doi:10.1371/journal.pntd.0000549.g001
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tandem with continued enhanced surveillance information, will be
used to determine raccoon rabies status for the area and whether
resources applied to this effort can be reallocated to other ORV
priorities.
Contingency actions are an integral component of rabies
management strategies in meso-carnivores to address local
emergencies that may arise during normal ORV operations.
However, such actions are labor intensive and wrought with
logistical and environmental challenges that mandate careful
coordination with the attendant high cost per unit area treated in
comparison to regularly planned ORV campaigns. Comprehen-
sive economic analysis of the benefits and costs associated with
the 2008 contingency action in Ohio are in progress and will
be compared to earlier reported estimates from Ontario that
suggest the costs are approximately 2.5 times greater than ORV
for a similar area [36]. Costs alone preclude their sustained
application on a landscape scale or at a high frequency, but
contingency actions remain important to address specific high-
risk rabies foci to restore or maintain the integrity of larger ORV
campaigns.
Key among the many challenges implicit in rabies control is the
pervasiveness of the translocation of raccoons and other meso-
carnivores [38], intentional or accidental, which represents a
common extrinsic threat for both local and long-range movement
of rabies and control programs [27]. Although translocation has
been instrumental in specific endangered species recovery efforts
and for other conservation purposes, large numbers of raccoons,
skunks, and other species are purposefully moved about the
landscape as a part of rehabilitation and nuisance wildlife control
efforts [38]. Raccoons and other animals that commonly feed on
household garbage may be unintentionally relocated considerable
distances in transport vehicles associated with interstate movement
of more than 42 million tons of municipal solid waste each year
[39]. The wildlife profession and others now question translocation
as a management tool in light of the need to contain or eliminate
high-profile, economically important wildlife diseases, including
rabies. Future plans will likely require a strategy that integrates at a
minimum outreach education and revised laws, accompanied by
enforcement, to make measurable inroads toward curbing this
widespread problem.
Vaccine-Bait-Biomarkers Needs
Adaptive methods for enhanced effectiveness in rabies control
require attention to a broad range of research needs. These
include ecology of reservoir species, an understanding of target
and non-target species foraging behaviors, community dynamics
of the meso-carnivore complex, bait uptake relative to a suite of
species-specific spatio-temporal variables, and model development
to support ORV decision making. Chief among these is the need
for improved or new baits and vaccines that lead to enhanced field
performance in raccoons and other species to reduce dependency
on contingency actions and allow a shift in focus toward
elimination strategies. This need is driven in part by rabies virus
spillover and establishment among several sympatric meso-
carnivores in North America [6,13,31]. Notably, no single vaccine
has proven efficacious under field conditions for all relevant
species. The community dynamics that lead to virus spillover
events and subsequent host shifts are not well understood nor have
the co-adaptive ecological relationships of the virus-host been
extensively studied [13,40,41]. Nevertheless, spillover events and
disease emergence present a challenge to the achievement of rabies
control objectives in the absence of effective oral vaccines for use
in the spillover host.
Notable examples of this dilemma have been documented in
Alaska and Canada, where arctic fox rabies virus variant has
spilled over into other animals, such as dogs and red foxes [42–44].
Infection of the latter species is especially problematic, because of
the broad geographic distribution of red foxes extending from the
arctic through the temperate zone, leading to subsequent spillover
and maintenance in the striped skunk [6]. Previously discussed
raccoon rabies virus variant spillover into striped skunks in the
eastern US, as well as a host shift of big brown bat (Eptesicus fuscus)
rabies virus to skunks near Flagstaff, Arizona, are other major
examples [45]. Clearly, enhancement of existing oral rabies
vaccine-bait combinations or the development of new products
with proven field effectiveness in the striped skunk as well as the
Figure 2. Raccoon variant rabies cases in Ohio contingency action zone. Since 16 July 2004 when raccoon rabies virus variant was
first detected west of the existing oral rabies vaccination zone, 117 animals have been confirmed positive with raccoon variant within the
contingency action zone. In 2007, no cases were detected via the public health surveillance system, illustrating the need for enhanced rabies
surveillance.
doi:10.1371/journal.pntd.0000549.g002
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Figure 3. Contingency actions in Ohio, 2008. A large-scale trap-vaccinate-release (TVR) operation was conducted near Cleveland, Ohio, in 2008
and resulted in the hand vaccination of 4,196 raccoons and the brainstem testing of 138 raccoons and 77 skunks. The TVR zone consisted of 185 cells
(1 km2 in size) and was delineated from raccoon variant rabies cases confirmed in the Contingency Action ORV zone in 2007 (n= 19). In addition to
TVR, oral rabies vaccine baits were distributed over the area as part of contingency actions in 2008.
doi:10.1371/journal.pntd.0000549.g003
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diverse complex of meso-carnivore rabies reservoir species in
North America is needed.
In Ontario, field trials were conducted recently with a human
adenovirus recombinant vaccine (ONRAB) developed with the
intent that its strategic use will facilitate the elimination of the fox
rabies foci maintained by skunks in southern Ontario [9]. Field
trials with ONRAB have also been extended to raccoon rabies
control in Ontario and Quebec. Several other new vaccine
constructs have been developed that may hold promise for use in
wildlife and dogs [46,47]. For example, a canine adenovirus
(CAV2) recombinant rabies vaccine may hold promise based upon
preliminary results obtained in captivity upon a variety of species
[48–52].
Tetracycline has had a long history as a biomarker in wildlife
management, including extensive use in evaluating bait uptake in
ORV campaigns [4,53,54], and its utility is well documented
[55–57]. Disadvantages, particularly for ORV in raccoons, is that
tooth extraction is intrusive, time consuming, and requires
anesthesia, as live trapped raccoons are released at their site of
capture once biological information and samples have been
collected. In addition, first and second premolars have much lower
tetracycline deposition rates than canine teeth, an unacceptable
candidate sample for extraction from live animals. Because of this,
tetracycline marking rates in raccoon premolar teeth from bait
consumption are variable and do not always exceed sero-
conversion rates as expected, compromising its usefulness as an
index to bait uptake. Contemporary issues associated with
antibiotic resistance and the uncertainty of tetracycline use in
the future obliges us to seek out effective, environmentally
compatible alternative biomarkers. Rhodamine B is one candidate
under study as a potential post-bait ingestion marker, which shows
promise in providing a short-term marker in growing whiskers as
well as long-term in teeth. Further study is required to assess its
field-level utility [58] as well as the feasibility of producing baits or
vaccine that incorporate Rhodamine B.
Rabies Control Intervention Revisited
In 2001, apparent spillover of big brown bat rabies virus variant
resulted in 19 documented cases in skunks near Flagstaff,
indicative of transmission among skunks [45]. Subsequent
intervention with TVR has resulted in periods of quiescence
followed by reemergence in 2004 and 2005 [21], and again in
2008 [59]. From 31 October 2008 – 1 May 2009, 17 cases of the
same big brown bat variant were confirmed in gray fox, a species
capable of longer range movement that could facilitate establish-
ment of this variant in foxes and skunks over a broader geographic
area [60,61]. While these events support the hypothesis of a viral
host shift from bats to carnivores, they also raise questions about
the potential relationship between human perturbations that
contributed to a locally abundant skunk population near Flagstaff
and the development of this situation. The more immediate
challenge is to determine if a practical and effective rabies
management strategy can be formulated and funded to contain
this apparently geographically limited focus. Elements of an
effective strategy under consideration include ORV of sufficient
scale to contain disease spread in gray foxes, periodic TVR in
skunks until an effective oral bait-vaccine combination is available,
and more comprehensive enhanced surveillance. The latter is to
better understand the temporal emergence and spatial spread of
bat rabies to susceptible carnivore populations. Failure to act while
this focus appears to be largely restricted to the Flagstaff vicinity
could result in the establishment of new terrestrial rabies variants
over a broader landscape that would present an even greater
challenge if control programs are contemplated in the future.
Other Wildlife Rabies Control Considerations
The cost effectiveness of the shifting paradigm toward
controlling rabies in meso-carnivore reservoirs should and will
receive continual scrutiny. To date, studies of the benefits and
costs have concluded that under specific assumptions and
scenarios, ORV is a viable rabies management alternative
[17,62–65]. Ultimately, sustainability of programs in a highly
competitive environment for government funding will hinge on
achieving measurable successes on finite timelines. The bait-
vaccine unit alone accounted for 88% of the ORV distribution
materials and services’ costs in the US, which included fuel and air
contracting for operations targeting raccoons at bait densities of
75/km2 during fiscal year 2008. Consequently, accelerated
Figure 4. Percent positive rabies antibody response ($0.05 IU).
doi:10.1371/journal.pntd.0000549.g004
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emphasis toward the development and production of low cost,
highly effective baits and oral vaccines that can clear the
regulatory process for broad scale use is a critical need.
Concomitantly, improvements to the currently licensed bait-
vaccine appear warranted if effectiveness can be enhanced while
cost/units are conserved. In turn, costs may be conserved by
refining baiting strategies based on validated models that point to
areas where reduced baiting density can be applied without
sacrificing effectiveness [66]. Past economic analyses should be
revisited to incorporate important new findings such as better
estimates for benefits and costs of contingency actions and use of
more powerful GIS analytical tools.
Concerns linger among some wildlife managers over potentially
negative consequences from rabies control to species of conserva-
tion concern [67]. The unique rabies virus variant adapted to
raccoons is a relatively new mortality factor, particularly in the
northeastern US and portions of southern Canada, having
reached southern New York in 1990, with an incursion into
southern Ontario in 1999, New Brunswick in 2000, and Quebec in
2006. The ecological dynamics of rabies in relation to other
raccoon disease mortality factors, such as canine distemper, have
not been extensively studied to determine if the effects on
populations are compensatory or additive. Clearly, additional
study on this topic is warranted from an ecological and
management perspective. Regardless, if raccoon predation is
having an impact on bird nesting species or other species of
concern [68,69], dependence on a solution that implies reliance on
the establishment of an unpredictable fatal virus, with tangibly
serious public and domestic animal health implications, represents
a dubious alternative to active management.
Summary
Establishment of a rabies management team composed of a
coalition of diverse expertise from the public health-agriculture-
wildlife management interface has been critical to facilitate
coordination among rabies control programs targeting meso-
carnivores in the US. The NARMP has established a continental
framework that extends collaboration and coordination, capacity
for rabies communications, surveillance, control, and research
among Canada, Mexico, and the US. Enhanced surveillance as a
complement to public health surveillance has improved decision-
making capability regarding allocation of rabies control resources,
including contingency actions to address emergencies, as illustrated
in Ohio. Raccoon rabies has not spread appreciably since ORV
intervention has expanded in the eastern US, yet rabies virus
neutralizing antibody levels in raccoon populations as an index to
immune buffers in existing ORV zones point to the need for
improved or new baits, oral vaccines, and strategy refinements.
Achieving advances that lead to improved field performance should
allow for a more aggressive movement of ORV zones into raccoon
enzootic areas. Measureable successes beyond containment would
be expected to enhance program sustainability toward the goal of
broader scale elimination of raccoon rabies and ultimately other
meso-carnivore rabies virus variants. Economic analyses will remain
integral to ORV planning and as a means to characterize successes
in costs and benefits. Conservation concerns related to control
programs cannot be ignored and require additional study to better
understand the role of rabies and other diseases on the population
dynamics of meso-carnivores, such as the raccoon.
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Key Learning Points
1. ORV represents a socially acceptable methodology that
has helped eliminate canine rabies from the US, and
restricted the distribution of raccoon, arctic fox, and gray
fox variants of rabies in North America.
2. An international rabies management team composed of
experts from the public health-agriculture-wildlife man-
agement interface has been vital to the establishment of
viable rabies control programs in North America.
3. ORV in the US remains focused on the raccoon variant of
rabies, while work continues to contain and eliminate the
gray fox rabies variant in west Texas, and prevent canine
rabies from re-emerging into the US from Mexico.
4. Advances in enhanced rabies surveillance that relies
largely on a direct rapid immunohistochemistry test have
led to improved real-time management decisions for
meso-carnivore rabies reservoir species in the US.
5. ORV-related dog research in the southwestern US has
potentially broad application in developing countries,
where most of the 55,000 human rabies cases per year
occur as the result of dog bites.
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